rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2009-12-4
|
pubmed:abstractText |
The aim of the study was to evaluate the impact of the genomic deletion of exon 3 of the GH receptor (d3GHR) on long-term clinical outcome of acromegaly in a well-characterized cohort of patients with long-term remission of acromegaly.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1945-7197
|
pubmed:author |
pubmed-author:BiermaszN RNR,
pubmed-author:CazemierMM,
pubmed-author:GuchelaarH-JHJ,
pubmed-author:HommesD WDW,
pubmed-author:KloppenburgMM,
pubmed-author:KroopH SHS,
pubmed-author:PereiraA MAM,
pubmed-author:RoelfsemaFF,
pubmed-author:RomijnJ AJA,
pubmed-author:SmitJ W AJW,
pubmed-author:WassenaarM J EMJ,
pubmed-author:van der KlaauwA AAA,
pubmed-author:van der StraatenTT
|
pubmed:issnType |
Electronic
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4671-8
|
pubmed:meshHeading |
pubmed-meshheading:19864451-Acromegaly,
pubmed-meshheading:19864451-Adult,
pubmed-meshheading:19864451-Aged,
pubmed-meshheading:19864451-Aged, 80 and over,
pubmed-meshheading:19864451-Anthropometry,
pubmed-meshheading:19864451-Bone Density,
pubmed-meshheading:19864451-Cardiovascular Diseases,
pubmed-meshheading:19864451-Cohort Studies,
pubmed-meshheading:19864451-Colonic Diseases,
pubmed-meshheading:19864451-DNA,
pubmed-meshheading:19864451-Exons,
pubmed-meshheading:19864451-Female,
pubmed-meshheading:19864451-Gene Deletion,
pubmed-meshheading:19864451-Genetic Predisposition to Disease,
pubmed-meshheading:19864451-Human Growth Hormone,
pubmed-meshheading:19864451-Humans,
pubmed-meshheading:19864451-Insulin-Like Growth Factor I,
pubmed-meshheading:19864451-Male,
pubmed-meshheading:19864451-Middle Aged,
pubmed-meshheading:19864451-Osteoarthritis,
pubmed-meshheading:19864451-Osteoporosis,
pubmed-meshheading:19864451-Polymorphism, Genetic,
pubmed-meshheading:19864451-Receptors, Somatotropin,
pubmed-meshheading:19864451-Risk Factors,
pubmed-meshheading:19864451-Spinal Fractures,
pubmed-meshheading:19864451-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
The exon-3 deleted growth hormone receptor polymorphism predisposes to long-term complications of acromegaly.
|
pubmed:affiliation |
Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
|
pubmed:publicationType |
Journal Article
|